Overview

Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan

Status:
COMPLETED
Trial end date:
2024-08-02
Target enrollment:
Participant gender:
Summary
This study aimed to determine the effect of introducing Basaglar and insulin pen injection devices on clinical and quality of life (QOL) parameters in children and young adults with type 1 diabetes in Pakistan
Phase:
PHASE4
Details
Lead Sponsor:
Life for a Child Program, Diabetes Australia
Collaborator:
Baqai Institute of Diabetology and Endocrinology
Treatments:
Insulin Glargine